As of 2023, the Indian biotechnology industry was valued at over ** billion U.S. dollars. The industry was expected to reach a market value of *** billion dollars by 2030. The growth of the industry would be driven by the increasing demand for vaccines and biopharmaceuticals in the domestic and international markets.

[227+ Pages Report] The India Biotechnology market size is expected to grow from USD 92.5 billion in 2023 to USD 421.2 billion by 2032, at a CAGR of 18.34% from 2024-2032

In India Biotechnology Market, It is fueled by groundbreaking advancements in genetic engineering, molecular biology, and genomics, which are transforming how we address global challenges such as disease, food security, and environmental sustainability.

The biopharmaceutical sector had the highest market value at about ** billion U.S. dollars among the various biotechnology market segments in India in 2023. The biotechnology market was valued at over ** billion dollars in the same period.

India Biotechnology Market Size, Trends and Insights By Technology (Tissue Engineering and Regenerative Medicine, Cell Based Assays, Chromatography, Polymerase Chain Reaction Technology (PCR), DNA Sequencing, Nanobiotechnology, Fermentation, Others), By Application (Healthcare Biotechnology, Agricultural Biotechnology, Industrial Biotechnology, Environmental Biotechnology), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

India Biotechnology Market was valued at USD 101.5 Billion in 2024 and is expected to reach USD 297.2 Billion by 2033, at a CAGR of 11.09% during the forecast period 2024 – 2033.

Biotechnology is essentially the use of living organisms and their processes to develop products or technologies. This can involve using bacteria to produce medicines, engineering crops to be more resistant to disease, or even creating new materials with unique properties.

The biotechnology market is booming, expected to reach over $4 trillion by 2033. This growth is driven by factors like rising awareness of health issues, advancements in areas like gene editing, and increased government funding for research.

The market itself is segmented into different areas like biopharmaceuticals, which include drugs and vaccines, and bio agriculture, which focuses on improving crops. There’s also bioinformatics, which uses computer science to analyse biological data, and bio services, which encompasses things like contract research.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=45749

Snapshot img

Biotech Market Size 2025-2029

The biotech market size is forecast to increase by USD 805.6 billion at a CAGR of 12.4% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing innovation and investment from market companies. These companies are expanding their research and development efforts to bring new products and technologies to market, addressing unmet medical needs and advancing scientific discoveries. However, this growth comes with challenges, primarily regulatory compliance. Stringent regulations governing the biotech industry ensure the safety and efficacy of products, but they also add costs and complexity to the development process. Biologics, comprised of monoclonal antibodies, vaccines, recombinant proteins, and cell and gene therapies, are derived from living organisms and cater to the treatment of numerous diseases, such as cancer, autoimmune disorders, and genetic conditions. Navigating these regulations requires the regulatory landscape and strategic planning.
For companies seeking to capitalize on market opportunities and navigate challenges effectively, it is essential to stay informed of the latest regulatory trends and best practices. Additionally, collaboration with regulatory agencies and industry experts can help streamline the development process and bring products to market more efficiently. Overall, the market presents significant opportunities for growth, but companies must be prepared to navigate regulatory complexities and invest in innovation to stay competitive.

What will be the Size of the Biotech Market during the forecast period?

Request Free Sample

The market encompasses a dynamic and innovative industry focused on advancing biological systems through engineering, gene therapies, and tissue culturing. This sector is driving progress in various areas, including medicine, environmental sustainability, and agriculture. Notable applications include the development of treatments for conditions such as HIV, diabetes, obesity, neurological disorders, and transfyretin amyloidosis. Significant investments continue to fuel market growth, with innovative companies spearheading clinical success in areas like personalized medicine and regeneration technologies. Biotech is also making strides in the production of genetically modified crops, leading to improved plant varieties and increased agricultural efficiency. Government support and approval processes are crucial components of the market's growth trajectory.
Technological advancements, such as molecular breeding and cloning, are revolutionizing the way we approach challenges in healthcare and agriculture. The biotech industry's positive outcomes extend beyond the conventional plan, with potential solutions for societal issues like malaria and sedentary lifestyle-related diseases. Market revenue is expected to grow substantially as biotech continues to deliver breakthroughs in medicine, bio-pharmaceuticals, and bio-agriculture. The future of this sector is bright, as it continues to push the boundaries of science and technology to address some of the world's most pressing challenges.

How is this Biotech Industry segmented?

The biotech industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Biologics
  Therapeutics
  Diagnostics
  Industrial biotechnology
  Others


Type

  Red biotechnology
  White biotechnology
  Green biotechnology
  Grey biotechnology
  Others


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Sweden
    Switzerland
    UK


  Asia
  Rest of World (ROW)

By Product Insights

The biologics segment is estimated to witness significant growth during the forecast period. The market encompasses a range of product categories, with biologics emerging as a key and expanding segment. In August 2023, Novartis finalized its acquisition of Chinook Therapeutics, Inc., a Seattle, WA-based biopharmaceutical company specializing in precision medicines for kidney diseases. Valued at up to USD 3.5 billion, this acquisition underscores the strategic significance of biologics within the global biotech sector. Biotechnology advancements in areas like gene editing, proteomics, and genomics continue to fuel innovation in disease treatment and prevention.

Biotech startups and established biopharma companies alike invest heavily in research and development, driving medical breakthroughs and healthcare solutions. The biotech industry's focus on patient care, disease management, and pharmaceutical innovation is transforming healthcare trends and improving health outcomes. Biotechnology education, policy, and regulation play crucial roles in fostering a sustainable and ethical industry.

Ge

Snapshot img

Agricultural Biotechnology Market Size 2024-2028

The agricultural biotechnology market size is forecast to increase by USD 28.63 billion at a CAGR of 9.6% between 2023 and 2028.

The market is experiencing significant growth, driven by the increasing demand for higher crop yield and the utilization of transgenic animals to produce recombinant proteins. This trend is particularly prominent in regions with a strong agricultural sector and a focus on food security. However, the market is not without challenges. The high costs associated with the development of agricultural biotechnology products pose a significant barrier to entry for new players. Additionally, regulatory oversight and public perception remain key challenges, as some stakeholders express concerns over the long-term health and environmental impacts of genetically modified organisms. Companies seeking to capitalize on market opportunities in Agricultural Biotechnology must navigate these challenges effectively, investing in research and development to reduce costs and build trust with consumers and regulators. Strategic partnerships and collaborations can also help mitigate risks and accelerate innovation. Overall, the market presents significant opportunities for companies that can effectively address these challenges and deliver sustainable, high-performing agricultural biotechnology solutions.

What will be the Size of the Agricultural Biotechnology Market during the forecast period?

Request Free SampleThe market encompasses the development and application of technology to improve the productivity, quality, and sustainability of plants, animals, and microbes in agriculture. This dynamic industry continues to evolve, driven by the demand for desirable traits such as virus resistance, herbicide-tolerance, insect-resistance, and enhanced quality traits. Genetic engineering, genome editing, and marker-assisted breeding are key technologies shaping the market, enabling the creation of transgenic seeds, stacked traits, and synthetic biology-enabled products. Genetic modifications also extend to animals, facilitating the development of vaccines and antibiotic development. In addition, the market is exploring the potential of biofuels, nutritional supplements, and flower culturing. The industry's focus on environmental conditions and the development of crop protection products contributes to its significant size and growth. Overall, the market is a vital sector, continuously innovating to meet the needs of a growing global population and evolving agricultural landscape.

How is this Agricultural Biotechnology Industry segmented?

The agricultural biotechnology industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductTransgenic seeds and cropsCrop protection biochemicalsOthersTypePlantsMicrobesAnimalsGeographyNorth AmericaUSEuropeGermanyUKAPACChinaIndiaSouth AmericaMiddle East and Africa

By Product Insights

The transgenic seeds and crops segment is estimated to witness significant growth during the forecast period.The market encompasses transgenic seeds, specifically those with herbicide-tolerant and insect-resistant traits, as well as stacked traits, which combine multiple genes. Corn, soybeans, and cotton are common crops with these characteristics. For instance, Bt seeds, a popular GM variety, incorporate parts of the Bacillus thuringiensis gene from a bacterium, producing toxins that harm specific insects, thereby enhancing insect resistance. The market dynamics include scientific methods such as genome editing, molecular methods, and marker-assisted selection, enabling the development of desirable traits in organisms. These advancements address micronutrient deficiencies, enhance nutritional value, and improve crop protection. However, there are concerns regarding the environmental impact, including potential antibiotic resistance and lack of knowledge about long-term effects. Geographical coverage, infrastructure, pricing, raw material shortage, and trade regulations are essential factors influencing the market. Partnerships between organizations and research focus on vaccine development, synthetic biology-enabled products, and capacity expansion. The availability of crop protection products, precision farming, and the impact on food security are also significant considerations. Despite these advancements, shipping delays and price trend analysis remain challenges. Organisms such as microbes and animals are also subject to genetic modification, expanding the market's scope. The technology's potential for improving human health and addressing nutritional supplements and antibiotic development is a driving force. However, the environmental impact and potential risks must be carefully considered.

India's Agriculture Biotechnology market projected to grow at 12% CAGR (2024-2029), fueled by increasing adoption of biotech solutions in farming.

The Indian bovine serum market is poised for substantial growth by 2029, driven by a burgeoning pharmaceutical and biotechnology sector, increasing research and development activities, and rising demand for high-quality cell culture media. While precise figures for 2029 are unavailable without specific market research data, we can project a reasonable estimate based on global trends and India's economic growth. Assuming a conservative Compound Annual Growth Rate (CAGR) of 8% – aligning with the growth observed in similar biopharmaceutical markets in developing economies – and considering a current market size (estimated for 2025), we can anticipate a significant expansion by 2029. The market's growth will be primarily fueled by the increasing adoption of bovine serum in various applications, including vaccine production, cell culture technologies, and diagnostic assays. Further segmentation within the market, based on serum type and application, will drive specialized production and sales, resulting in a diversified market landscape. Government initiatives supporting the pharmaceutical and biotech industry in India will also play a crucial role in enhancing market growth. Challenges, however, may include sourcing high-quality raw materials and maintaining consistent serum quality and production standards. The projected growth in the Indian bovine serum market will likely be uneven across different regions. Larger metropolitan areas with established pharmaceutical and biotechnology hubs will witness higher demand compared to less developed regions. Furthermore, the increasing focus on regulatory compliance and stringent quality control measures will shape market dynamics, encouraging the adoption of advanced technologies and potentially leading to consolidation among market players. The market will continue to see an increased demand for customized serum products tailored to specific cell lines and research applications, driving innovation and further specialization within the industry. The coming years will see a rise in competition, with both domestic and international companies vying for market share, fostering innovation and price competitiveness, ultimately benefiting end users.

In India Animal Biotechnology Market , was valued at approximately USD 10.11 billion in 2022 and is projected to reach USD 12.45 billion by 2029,

The biotechnology market size was valued at USD 1.64 trillion in 2024 and is expected to grow at a CAGR of 13.6% from 2025 to 2034

The India Preclinical CRO Market Report is Segmented by Services (Toxicity Studies, Drug Metabolism and Pharmacokinetics Studies, Scientific Advisory Services, in Vivo Pharmacology Services, and Others) and End User (Pharmaceutical and Biotechnology Companies, Academic Centers and Research Institutes, and Others). The Report Offers the Value (USD) for the Above Segments.

Comprehensive dataset of 254 Biotechnology engineers in India as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Introduction

The Global AI in Biotechnology Market is projected to reach approximately US$ 26.3 Billion by 2033, growing at a robust CAGR of 19.3% from 2024 to 2033. In 2023, the market was valued at US$ 4.5 Billion. North America holds a dominant position in the market, capturing over 40.8% of the share with a market value of US$ 1.8 Billion. The growing adoption of Artificial Intelligence (AI) in biotechnology is largely driven by the increasing need for more efficient and cost-effective solutions in drug discovery, manufacturing processes, and diagnostics.

AI integration in biotechnology has brought about significant advancements, particularly in drug discovery and development. AI algorithms are adept at analyzing large datasets to identify potential drug candidates and predict their efficacy. This accelerates the drug discovery process, significantly reducing both time and costs. As a result, therapies are brought to market faster, benefiting both pharmaceutical companies and patients. AI’s role in streamlining R&D processes is a key growth driver in the sector.

Personalized medicine is another significant trend contributing to the expansion of AI in biotechnology. By analyzing genetic profiles and patient data, AI helps design individualized treatment plans. This personalized approach improves the effectiveness of treatments while minimizing adverse effects, in line with the growing shift toward personalized healthcare. This not only increases patient satisfaction but also reduces healthcare costs, making it a key area of investment for biotechnology companies worldwide.

AI’s ability to optimize biomanufacturing processes is enhancing operational efficiencies in biotechnology industries. In countries like India, where the biotechnology sector is experiencing rapid growth, AI is crucial in driving efficiencies. India’s bioeconomy target of $150 billion by 2025 reflects the increasing reliance on AI in biomanufacturing. Moreover, AI also supports regulatory compliance by ensuring that products meet necessary standards, which accelerates time-to-market and supports industry sustainability.

Governments globally are investing heavily in AI and biotechnology, further fostering market growth. For instance, India’s commitment to the biotechnology sector is evident through its ambitious target of reaching a $600 billion bioeconomy by 2030. These strategic government initiatives help fuel innovation and enable the development of more advanced AI-driven solutions, improving healthcare outcomes and expanding the potential applications of biotechnology. With these ongoing developments, the AI in biotechnology market is poised for sustained growth and transformation.

https://market.us/wp-content/uploads/2024/12/AI-in-Biotechnology-Market-Size.jpg" alt="AI in Biotechnology Market Size">

India Red Biotechnology Market growth is driven by challenges like regulatory bottlenecks and high costs remain, advancements in AI, CRISPR, and regenerative medicine.

Snapshot img

Marine Biotechnology Market Size 2025-2029

The marine biotechnology market size is forecast to increase by USD 5.53 billion at a CAGR of 10.5% between 2024 and 2029.

The market is experiencing significant growth, driven primarily by the increasing demand for sustainable biofuels and the urgent need to address climate change. This sector holds immense potential as marine organisms offer a rich source of bioactive compounds and renewable resources. However, the market is not without challenges. Legal and ethical issues surrounding the use of marine organisms and their genetic material remain a concern, necessitating stringent regulatory frameworks. Another trend in the market is the use of transgenic animals for producing recombinant proteins, which holds immense potential for the production of pharmaceuticals and industrial enzymes. Companies operating in this space must navigate these complexities to capitalize on the opportunities presented by this dynamic market. The trend towards developing eco-friendly technologies and products, coupled with advancements in genetic engineering and bioprospecting, is expected to fuel market growth.
Strategic partnerships, collaborations, and investments in research and development will be key to staying competitive in this evolving landscape. Companies seeking to capitalize on the opportunities in Marine Biotechnology must remain agile, innovative, and committed to sustainable practices to succeed in this market.

What will be the Size of the Marine Biotechnology Market during the forecast period?

Request Free Sample

The market encompasses a diverse range of applications, from the exploration and utilization of marine bacteria and fungi for biofouling control and the production of bioactive peptides, lipids, and natural products, to the application of biotechnology tools such as high-throughput screening, synthetic biology, gene expression, and next-generation sequencing. This burgeoning industry also includes the development of bioprocess engineering and bioreactor design for the production of biocatalysts, as well as the implementation of bioremediation technologies for marine pollution control. Sustainable fisheries, marine ecosystem restoration, oceanographic modeling, and marine environmental monitoring are further areas of focus. Synthetic biology-enabled products, such as genome editing and marker-assisted breeding, further accelerate the development of new traits.
Additionally, marine biotechnology is exploring new frontiers in marine bioenergy, carbon sequestration, policy, ethics, and education. The market's growth is driven by the vast potential of the marine environment as a source of novel biological compounds and processes, as well as the increasing demand for sustainable and eco-friendly solutions to global challenges. For instance, vaccines and antibiotics are being developed using these technologies to improve animal health and productivity.

How is this Marine Biotechnology Industry segmented?

The marine biotechnology industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Application

  Healthcare products
  Energy and environment management products
  Food and cosmetics products


Type

  Bio active substance
  Bio materials
  Others


Source

  Algae
  Marine fungi
  Corals and sponges
  Marine viruses
  Others


Technology

  Isolation and cultivation of microorganisms
  Culture-independent techniques


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Application Insights

The healthcare products segment is estimated to witness significant growth during the forecast period. Marine biotechnology is a dynamic and innovative field that offers significant potential for the discovery and development of new bioactive compounds. These compounds, derived from marine invertebrates, algae, and microorganisms, differ from their terrestrial counterparts and hold promise as novel medicines. For instance, marine-derived drugs include an antibiotic produced from fungi, two anti-cancer and herpes virus treatments from a sponge, and a painkiller from a snail that is 10,000 times more potent than morphine without its side effects. The marine invertebrate, Bugula neritina, is a potential source for a leukemia drug. Marine genomics, microbiology, and enzymology are key areas of research that contribute to the discovery of these bioactive compounds.

Furthermore, marine biotechnology has applications in sustainable aquaculture, bioremediation, biofuel production, and biomaterials. The industry is driven by advancements in gene editing, biotechnology platforms, and p

The global biotechnology instrument market is calculated at US$ 67.24 billion in 2024, as revealed in the updated market research report by Fact.MR. Worldwide sales of biotechnology instruments are evaluated to accelerate at 12.5% CAGR and reach US$ 218.11 billion by the end of 2034.

Report Attribute	Detail
Biotechnology Instrument Market Size (2024E)	US$ 67.24 Billion
Forecasted Market Value (2034F)	US$ 218.11 Billion
Global Market Growth Rate (2024 to 2034)	12.5% CAGR
Market Share of Pharmaceutical & Biotechnology Companies (2034F)	37%
South Asia & Pacific Market Share (2034F)	21.6%
Canada Market Growth Rate (2024 to 2034)	18.5% CAGR
Key Companies Profiled	Waters Corporation; F. Hoffmann-La Roche Ltd.; Abbott; Zimmer MedizinSysteme; Agilent Technologies; Thermo Fisher Scientific, Inc.; BioMerieux SA; Siemens Healthineers; Bio-Rad Laboratories; Perkin Elmer, Inc.; BioTek Instruments, Inc.; Novanta, Inc.; Candela Medical; Merck KGaA; Cynosure, LLC; IIlumina Inc.; Danaher Corporation.

Country-wise Insights

Attribute	United States
Market Value (2024E)	US$ 20.72 Billion
Growth Rate (2024 to 2034)	14.1% CAGR
Projected Value (2034F)	US$ 77.44 Billion

Attribute	India
Market Value (2024E)	US$ 3.25 Billion
Growth Rate (2024 to 2034)	18.4% CAGR
Projected Value (2034F)	US$ 17.65 Billion

Attribute	South Korea
Market Value (2024E)	US$ 2.41 Billion
Growth Rate (2024 to 2034)	13.1% CAGR
Projected Value (2034F)	US$ 8.27 Billion

Category-wise Insights

Attribute	Biotechnology Lab Automation Instruments
Segment Value (2024E)	US$ 33.78 Billion
Growth Rate (2024 to 2034)	12.8% CAGR
Projected Value (2034F)	US$ 112.67 Billion

Attribute	Pharmaceutical & Biotechnology Companies
Segment Value (2024E)	US$ 25.94 Billion
Growth Rate (2024 to 2034)	12% CAGR
Projected Value (2034F)	US$ 80.61 Billion

The Indian zebrafish market is poised for significant growth in 2029, driven by increasing demand in research and development, particularly in the pharmaceutical and biomedical sectors. Zebrafish, known for their genetic similarity to humans and ease of observation, are becoming increasingly crucial for drug discovery, disease modeling, and toxicological studies. The rising prevalence of chronic diseases and the growing need for effective treatments are further boosting the market. India's burgeoning biotechnology sector, coupled with government initiatives promoting scientific research, is creating a favorable environment for the expansion of the zebrafish market. While precise market figures for 2029 require further granular data, a conservative estimate based on a projected Compound Annual Growth Rate (CAGR) of 15% (a reasonable estimate considering global trends) from a 2025 base of ₹500 million (approximately $60 million USD) suggests a market value exceeding ₹1.2 billion (approximately $144 million USD) by 2029. This growth is likely to be concentrated in the research and academic segments, with increasing adoption in pharmaceutical companies as well. However, challenges remain, including infrastructure limitations in certain research facilities and a potential skills gap in handling and maintaining zebrafish colonies. Overcoming these obstacles through public-private partnerships and investment in training programs will be crucial for sustaining this positive trajectory. Furthermore, the development and availability of advanced zebrafish-related technologies and services will greatly impact market expansion. The specific application of zebrafish in disease modelling (cancer, neurological disorders, etc.) and drug screening is predicted to drive substantial growth. The market segmentation will likely see a strong emphasis on the supply of zebrafish models (wild-type and transgenic lines) and related services such as breeding, housing, and imaging. The accessibility of advanced technologies like CRISPR-Cas9 gene editing for zebrafish is expected to create new opportunities. The competitive landscape will consist of both established international suppliers and emerging Indian companies offering various services along the value chain. The growth is likely to be uneven across regions, with major metropolitan areas and established research hubs leading the way.

India Biological Crop Protection Market was valued at USD 80.48 Million in 2024 and is anticipated to project impressive growth with a CAGR of 6.38% during forecast period.

Pages	80
Market Size	2024: USD 80.48 Million
Forecast Market Size	2030: USD 116.13 Million
CAGR	2025-2030: 6.38%
Fastest Growing Segment	Bioinsecticides
Largest Market	West India
Key Players	1. T. Stanes & Company Ltd. 2. Agri Life Ltd. 3. UPL Ltd. 4. IPL Biologicals Ltd. 5. Kan Biosys Pvt. Ltd. 6. Manidharma Biotech Pvt. Ltd. 7. Aumgene Biosciences Pvt. Ltd. 8. Criyagen Agri And Biotech Pvt. Ltd. 9. Varsha Bioscience and Technology India Pvt. Ltd. 10. PI Industries Ltd.

Subscribers can find out export and import data of 23 countries by HS code or product’s name. This demo is helpful for market analysis.